||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 527 active entries
668 N Mayfair Ave.
Daly City, 94015
United States of America, California
Phone: (650) 758-3658
Fax: (650) 758-3768
Pleiades, Inc. specializes in the design and engineering of biotechnology and pharmaceutical plants. Our company can assist you in all phases of your project, from conceptual engineering to start up, commissioning, and validation of your pilot or manufacturing facility for the production of active biological proteins and organic synthetic drugs. We can also assist you in the preparation of your documentation and the training of your personnel (e.g., SOPs, Instrumentation Calibration, PMs). Our knowledge in cGMP assures you of a system designed to be validatable and in compliance with NIH guidelines and the FDA’s Code of Federal Regulations. We are committed to work with you as your design partner. We provide a personal approach in getting your development, manufacturing, QC/QA, validation and maintenance support groups to actively participate in the evolution of the design phase. The corporation is built upon a core of senior process engineers, control systems engineers, equipment engineers, and validation specialists supported by associates available for specific project assignment within their specialty areas. We have extensive experience with process and process utility support systems, including media prep, fermenter/bioreactor, buffer prep, purification, glass washer, sterilizer, RO/DI, WFI, Pure Steam, compressed gas, chilled water, CIP, cell inactivation, and waste neutralization systems. Projects include: the conceptual design/preliminary engineering of a cell culture, multi-product pilot plant for the production of monoclonal antibodies; detailed design/engineering/validation of a pilot plant for the manufacture of a rare enzyme; and the conceptual design of a R&D facility for mammalian cell culture and bacterial fermentation products. For more information, please visit us at Pleiades, Inc.
Last update of this entry: April 10, 2018